Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
AMGEN INC entered into Officer's Certificate valued at $1,000,000,000 aggregate principal amount of the Company’s 4.200% Senior Notes due 2031, $1,750,000, (effective 2026-02-19).
- Action
- entry
- Agreement
- notes offering
- Value
- $1,000,000,000 aggregate principal amount of the Company’s 4.200% Senior Notes due 2031, $1,750,000,
- Effective
- 2026-02-19
Exact text from the filing
On February 17, 2026, Amgen Inc. (the “Company”) issued and sold $1,000,000,000 aggregate principal amount of the Company’s 4.200% Senior Notes due 2031 (the “2031 Notes”), $1,750,000,000 aggregate principal amount of the Company’s 4.850% Senior Notes due 2036 (the “2036 Notes”), $500,000,000 aggregate principal amount of the Company’s 5.500% Senior Notes due 2046 (the “2046 Notes”) and $750,000,000 aggregate principal amount of the Company’s 5.650% Senior Notes due 2056 (the “2056 Notes” and, together with the 2031 Notes, the 2036 Notes and the 2046 Notes, the “Notes”).
View on SEC.gov